John Elflein
Research expert covering health and health care
Detailed statistics
Top ten causes of global deaths 2019
Detailed statistics
Global death rate - leading causes 2019
Detailed statistics
Distribution of global respiratory-immunology market by condition 2022-2023
Prevalence of COPD among U.S. adults in 2011 and 2021, by smoking status
Percentage of adults in the U.S. with chronic obstructive pulmonary disease (COPD) in 2011 and 2021, by smoking status
Prevalence of COPD among U.S. adults as of 2017, by smoking status and gender
Percentage of adults in the U.S. with chronic obstructive pulmonary disease (COPD) as of 2017, by smoking status and gender
Prevalence of COPD among U.S. adults as of 2017, by smoking status and age
Percentage of adults in the U.S. with chronic obstructive pulmonary disease (COPD) as of 2017, by smoking status and age
Prevalence of COPD among U.S. adults as of 2017, by smoking status and ethnicity
Percentage of adults in the U.S. with chronic obstructive pulmonary disease (COPD) as of 2017, by smoking status and ethnicity
COPD among U.S. adults as of 2017, by smoking status and urban-rural status
Percentage of adults in the U.S. with chronic obstructive pulmonary disease (COPD) as of 2017, by smoking status and urban-rural status
COPD prevalence in the U.S. 2021, by state
Prevalence of chronic obstructive pulmonary disease (COPD) in the U.S. in 2021, by state
COPD prevalence among former smokers in the U.S. 2017, by state
Prevalence of chronic obstructive pulmonary disease (COPD) among former smokers in the U.S. in 2017, by state
COPD prevalence among current smokers in the U.S. 2017, by state
Prevalence of chronic obstructive pulmonary disease (COPD) among current smokers in the U.S. in 2017, by state
Prevalence of COPD among employed non-smokers in the U.S. 2013-2017, by gender
Percentage of employed adults in the U.S. who never smoked but had chronic obstructive pulmonary disease (COPD) from 2013 to 2017, by gender
Prevalence of COPD among employed non-smokers in the U.S. from 2013-2017, by age
Percentage of employed adults in the U.S. who never smoked but had chronic obstructive pulmonary disease (COPD) from 2013 to 2017, by age
Prevalence of COPD among employed non-smokers U.S. 2013-2017, by ethnicity
Percentage of employed adults in the U.S. who never smoked but had chronic obstructive pulmonary disease (COPD) from 2013 to 2017, by ethnicity
Prevalence of COPD among employed non-smokers U.S. 2013-2017, by region
Percentage of employed adults in the U.S. who never smoked but had chronic obstructive pulmonary disease (COPD) from 2013 to 2017, by region
Prevalence of COPD among employed non-smokers U.S. 2013-2017, by industry
Percentage of employed adults in the U.S. who never smoked but had chronic obstructive pulmonary disease (COPD) from 2013 to 2017, by industry
Prevalence of COPD among employed non-smokers U.S. 2013-2017 by occupation
Percentage of employed adults in the U.S. who never smoked but had chronic obstructive pulmonary disease (COPD) from 2013 to 2017, by occupation
COPD prevalence among non-smokers in the U.S. 2017, by state
Prevalence of chronic obstructive pulmonary disease (COPD) among adults who never smoked in the U.S. in 2017, by state
Leading causes of death in the United States 2022
Distribution of the 10 leading causes of death in the United States in 2022
Rates of the leading causes of death in the U.S. 2022
Rates of the 10 leading causes of death in the United States in 2022* (per 100,000 population)
COPD death rate among U.S. adults from 1999 to 2021, by gender
Death rate from chronic obstructive pulmonary disease (COPD) among adults in the U.S. from 1999 to 2021, by gender (per 100,000 population)
COPD death rate among U.S. adults from 2000 to 2014, by ethnicity
Number of deaths from Chronic Obstructive Pulmonary Disease (COPD) among adults in the U.S. from 2000 to 2014, by ethnicity (per 100,000 population)
COPD death rate among older U.S. adults in 2014, by age and gender
Number of deaths from Chronic Obstructive Pulmonary Disease (COPD) among older adults in the U.S. in 2014, by age and gender (per 100,000 population)
COPD death rate in the U.S. 2015, by urban-rural status
Rate of death from Chronic Obstructive Pulmonary Disease (COPD) in the U.S. in 2015, by urban-rural status (per 100,000 population)
Leading underlying causes of death among COPD deaths in the U.S. in 2014, by gender
Distribution of leading underlying causes of death for Chronic Obstructive Pulmonary Disease-related deaths among adults in the U.S. in 2014, by gender
Number of adult smokers in the United States 1965-2021
Number of current adult smokers in the United States from 1965 to 2021* (in millions)
U.S. smoking prevalence among adults by race and ethnicity 2021
Prevalence of smoking among U.S. adults as of 2021, by race and ethnicity
Percentage of adults in the U.S. who smoke as of 2022, by state
Percentage of adults who smoke in the United States as of 2022, by state
U.S. adult tobacco product use in 2021, by age
Percentage of U.S. adults that used various forms of tobacco products in 2021, by age
Exacerbation in the past year among those with COPD in the U.S. as of 2020
Percentage of individuals in the U.S. with Chronic Obstructive Pulmonary Disease who suffered from exacerbation a select number of times in the past year as of 2020
Symptoms experienced by individuals in the U.S. with COPD in 2020
Percentage of individuals in the U.S. with Chronic Obstructive Pulmonary Disease who experienced select symptoms as of 2020
Comorbidities experienced among U.S. adults with COPD as of 2019
Percentage of those diagnosed with chronic obstructive pulmonary disease (COPD) in the U.S. who experienced select other conditions as of 2019
Tests commonly used for diagnosing COPD in the U.S. 2018
Percentage of individuals in the U.S. with Chronic Obstructive Pulmonary Disease who were diagnosed using select tests as of 2018
Treatments and alternative therapies used by those with COPD in the U.S. as of 2018
Percentage of individuals in the U.S. with Chronic Obstructive Pulmonary Disease who used select treatments and alternative therapies as of 2018
U.S. aggregate costs of potentially preventable inpatient stays in 2017, by condition
Aggregate costs of preventable adult inpatient hospital stays in the United States in 2017, by condition type (in billion U.S. dollars)
U.S. mean cost per stay of potentially preventable inpatient stays 2017, by condition
Mean cost per stay of preventable adult inpatient hospital stays in the United States in 2017, by condition type (in U.S. dollars)
Asthma/COPD drug PMPM spending U.S. 2019-2024
Asthma and COPD drug PMPM spending in the United States from 2019 to 2024 (in U.S. dollars)
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)